The startup develops a biomimetic leaflet material for heart valve replacements that enhances durability beyond current manufacturing limitations. This technology enables healthcare professionals to provide longer-lasting solutions for patients with heart disease, improving their quality of life.
Funding
$350K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current tissue-based heart valve replacements face limitations in durability and high manufacturing costs, leading to potential deterioration and the need for re-do procedures. The sourcing and processing of animal tissues also contribute to supply chain complexities and waste.
Solution
Lifelet Medical is developing a fully synthetic, polymer-based biomimetic leaflet material for heart valve replacements that overcomes the limitations of existing tissue valves. This technology aims to provide a more durable and cost-effective solution, reducing the need for repeat surgeries and improving long-term clinical outcomes for patients with heart valve disease. By eliminating the use of animal tissue, Lifelet Medical's approach streamlines the supply chain, reduces waste, and offers a sustainable alternative for heart valve replacement. The implantable polymer technology is designed for ease of manufacturing and aims to provide a "one valve for life" solution.
Target Audience
The primary target audience includes cardiac surgeons and hospitals seeking durable, cost-effective, and sustainable heart valve replacement solutions for patients with heart valve disease.
Features
- Fully synthetic, polymer-based biomimetic material
- Designed for increased durability and reduced deterioration compared to tissue valves
- Streamlined and cost-effective manufacturing process
- Sustainable solution eliminating the need for animal tissue sourcing
- Aims to reduce the need for re-do procedures